INOVIO Announces First Subject Dosed in Phase 1B Clinical Tria...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
PLYMOUTH MEETING, Pa., Feb. 23, 2021 /PRNewswire-AsiaNet/ -- -- Phase 1B clinical trial is first study for Lassa fever conducted in Africa -- Goal is for vaccine to be available for emergency use as stockpile product following Phase 2 -- Progress on INO-4500 reflects INOVIO's focus on an...
Authors: LATEST ASIANET NEWS RELEASES